Clinical Trial

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Completed Phase 4
View on ClinicalTrials.gov →
Summary
People with acute inferior wall myocardial infarction will be given an intravenous drug called atropine that increases the heart rate to check if it prevents heart rhythm disturbances during performing coronary intervention
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-04.
Status change: Recruiting → Completed 2026-03-09
Trial Details
NCT Number NCT07268586
Lead Sponsor Ain Shams University
Conditions Myocardial Infarction
Enrollment 158 participants
Start Date 2025-08-01
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-10